BridgeMD
New treatment option for ESCAPE Intervention+NRT
Official title Enhancing Smoking Cessation for African American People Everywhere
ClinicalTrials.gov ID: NCT07024992
What this study is testing
- What it's testing
- The present study aims to investigate the efficacy of an mHealth smoking cessation and HIV disease management intervention among a nationally representative sample of African America/Black (hereafter refer to as Black) persons with HIV/AIDS (PWH) who smoke cigarettes. Participants will be randomized into one of three conditions: (1) the intervention, ESCAPE (Enhancing Smoking Cessation for African American People Everywhere) + Nicotine Replacement Medications (NRT), (2) the National Cancer Institute's (NCI) quitSTART app, the standard mobile smoking cessation treatment + NRT, and (3) an assessment-only control group + NRT.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- At least 18 years of age
- Identify as Black/African American
- Living with HIV
- Biochemical verification of self-reported smoking status following minimum study specified smoking rate endorsement
- Motivated to quit smoking
You likely can't join if
- Legal situations which may interfere with study participation
- Not being fluent in English
- High blood pressure that is not under control
- Having experienced a heart attack within the past 2 weeks
- Pregnant of planning to become pregnant within the next six months
See the full eligibility criteria
- At least 18 years of age
- Identify as Black/African American
- Living with HIV
- Biochemical verification of self-reported smoking status following minimum study specified smoking rate endorsement
- Motivated to quit smoking
- Must be ready to quit cigarettes within 14 days of full enrollment
- Moderate or higher anxiety sensitivity OR elevated anxiety OR depression
- Must be willing to download a mobile app onto their personal phone
- Must be willing to use NRT
- Possess an Android/Apple smartphone that is compatible with the mobile app
- Demonstrate 7th grade level proficiency in English (≥4 on the Rapid Estimate of Adult Literacy in Medicine-Short Form [REALM-SF])
- Valid proof of identification (photo of valid US ID)
- Legal situations which may interfere with study participation
- Not being fluent in English
- High blood pressure that is not under control
- Having experienced a heart attack within the past 2 weeks
- Pregnant of planning to become pregnant within the next six months
The study team makes the final eligibility decision.
Where it's taking place
- Oklahoma City, Oklahoma, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oklahoma City, Oklahoma, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.